The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Daiichi Sankyo; Hexal; Novartis; Pfizer; Roche
Consulting or Advisory Role - Daiichi Sankyo; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer
 
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Genentech; Genomic Health; MSD; Novartis; Pfizer; pfm medical; Puma Biotechnology; Roche; SOMATEX
Travel, Accommodations, Expenses - Daiichi Sankyo; Roche
RIBECCA: A phase IIIb, multicenter, open label study for women with estrogen receptor-positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in combination with letrozole—Results of the second interim analysis.
 
Arnd Nusch
Consulting or Advisory Role - Novartis; Roche
Research Funding - Novartis (Inst); Roche (Inst)
 
Thomas Decker
Consulting or Advisory Role - Novartis
 
Mattea Reinisch
No Relationships to Disclose
 
Andreas D. Hartkopf
No Relationships to Disclose
 
Bernhard Heinrich
Consulting or Advisory Role - Bristol-Myers Squibb; Lilly; Novartis; Roche; Sanofi
Research Funding - Bristol-Myers Squibb; Clovis Oncology; Janssen-Cilag; Lilly; Novartis; Roche; Sanofi
 
Christian M. Kurbacher
Honoraria - Amgen; AstraZeneca; Mundipharma; Novartis; Onkotrakt; Pfizer; PharmaMar; RIEMSER; Roche; Tesaro
Consulting or Advisory Role - Amgen; Axios; Hilotherm; Mundipharma; NewCo Pharma; Novartis; RIEMSER; Roche; Tesaro
Research Funding - AstraZeneca; Axios; Merck Sharp & Dome; NewCo Pharma; Novartis; Pfizer; PharmaMar; RIEMSER
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Hexal; PharmaMar; Tesaro; Teva
 
Roswitha Dorothea Fuchs
No Relationships to Disclose
 
Hans Tesch
Honoraria - Novartis; Pfizer; Roche Pharma AG
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche Pharma AG
 
Petra Krabisch
No Relationships to Disclose
 
Sara Brucker
Consulting or Advisory Role - Roche, Novartis, Pfizer
Research Funding - Novartis, Roche, Pfizer (Inst)
Travel, Accommodations, Expenses - Roche, Novartis, Pfizer
 
Tanja N. Fehm
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Novartis; Pfizer; Roche
Research Funding - Novartis
 
Wolfgang Janni
Honoraria - AstraZeneca; Janssen Diagnostics; Lilly; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Lilly; Menarini Silicon Biosystems; Novartis; Pfizer; Roche
Research Funding - Amgen (Inst); Janssen Diagnostics; Lilly (Inst); Menarini Silicon Biosystems; Novartis (Inst); Pfizer (Inst); Roche (Inst)
 
Sherko Kümmel
No Relationships to Disclose
 
Diana Luftner
Honoraria - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; Novartis; Pfizer; Sanofi; Tesaro; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; Novartis; Pfizer; Sanofi; Tesaro; Teva
Speakers' Bureau - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; Novartis; Pfizer; Sanofi; Tesaro; Teva
Research Funding - Novartis (Inst)
Expert Testimony - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; Novartis; Pfizer; Sanofi; Tesaro; Teva
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Celgene; L'Oreal; Lilly; Novartis; Pfizer; Sanofi; Tesaro; Teva
 
Andreas Schneeweiss
Honoraria - AstraZeneca; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Tesaro
Research Funding - Abbvie; Celgene (Inst); Molecular Partners; Roche Pharma AG (Inst)
Expert Testimony - AstraZeneca; Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Martin H. Schuler
Honoraria - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Novartis; Roche
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Highly sensitive method for mutation detection by PCR (Inst)
 
Claudia Voges
Employment - Novartis
 
Joerg Schubert
Employment - Novartis
 
Peter A. Fasching
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Hexal; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Hexal; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche; Teva
Research Funding - BioNTech (Inst); Novartis (Inst)